Cardiovascular outcomes trial data from EMPA‐REG OUTCOME , CAROLINA and CARMELINA : Assessment of a novel staging system for type 2 diabetes
Open Access
- 6 March 2023
- journal article
- research article
- Published by Wiley in Diabetes, Obesity and Metabolism
- Vol. 25 (5) , 1372-1384
Abstract
Aims: To apply the diabetes staging system (DSS), a novel disease staging system similar to what is used in oncology but designed to improve diabetes management, to three large type 2 diabetes (T2D) cardiovascular (CV) outcome trials to assess whether increasing DSS stage was associated with higher rates of all‐cause mortality (ACM) and/or CV death. Materials and Methods: The DSS uses discrete CV events (none to ≥3: Stage 1 to 4), end‐stage kidney disease (Stage 5) and microvascular complications (none to 3: A to D) to determine disease stage in individuals with T2D. The DSS stage for patients from the CAROLINA, EMPA‐REG OUTCOME and CARMELINA trials was determined. Incidence rates for ACM/CV death were calculated across DSS stages and Cox regression analyses were performed. Results: The risk of ACM or CV death increased with increasing DSS (Stage 1 to 5; P for trend P for trend P for trend = 0.0020 and 0.0005, respectively). In EMPA‐REG OUTCOME, having all three microvascular complications (Stage D), versus none, increased the risk of ACM and CV death ( P = 0.0015 and 0.0010, respectively). Conclusions: Applying the DSS across T2D clinical trial populations with different CV risk revealed a significantly increased risk of ACM and CV death with higher DSS stage. The DSS may merit assessment in other T2D populations and evaluation of the impact of additional outcomes, such as heart failure, could also be worthwhile.Keywords
This publication has 19 references indexed in Scilit:
- Ovarian Cancer, the Revised FIGO Staging System, and the Role of ImagingAmerican Journal of Roentgenology, 2016
- Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 DiabetesNew England Journal of Medicine, 2015
- Brief Note Staging of type 2 diabetes mellitusGenetics and Molecular Research, 2015
- A simple diabetes vascular severity staging instrument and its application to a Torres Strait Islander and Aboriginal adult cohort of north AustraliaBMC Health Services Research, 2012
- Projection of the year 2050 burden of diabetes in the US adult population: dynamic modeling of incidence, mortality, and prediabetes prevalencePopulation Health Metrics, 2010
- Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysisThe Lancet, 2010
- Reduced Kidney Function as a Risk Factor for Incident Heart FailureJournal of the American Society of Nephrology, 2007
- UISESS scale for staging and classifying clinical–epidemiological risk in type 2 diabetes mellitus and for establishing multidiscipinary preventive actionsPreventive Medicine, 2005
- Chronic Kidney Disease and the Risks of Death, Cardiovascular Events, and HospitalizationNew England Journal of Medicine, 2004
- Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34)The Lancet, 1998